{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:13:00Z","timestamp":1762099980396,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["2I01BX000559"],"award-info":[{"award-number":["2I01BX000559"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.biopsych.2022.05.018","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T05:12:14Z","timestamp":1657516334000},"page":"175-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["From Ketamine to Drugs Targeting Subtype-Selective Benzodiazepine Site-Containing Gamma-Aminobutyric Acid A Receptors as Novel Rapid-Acting Antidepressants"],"prefix":"10.1016","volume":"92","author":[{"given":"Flavia Regina","family":"Carreno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2022.05.018_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/mp.2017.255","article-title":"Mechanisms of ketamine action as an antidepressant","volume":"23","author":"Zanos","year":"2018","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2022.05.018_bib2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.tins.2015.03.003","article-title":"An excitatory synapse hypothesis of depression","volume":"38","author":"Thompson","year":"2015","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.biopsych.2022.05.018_bib3","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2174\/156802611795371314","article-title":"GABAA receptor subtype-selective modulators. II. \u03b15-selective inverse agonists for cognition enhancement","volume":"11","author":"Atack","year":"2011","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.biopsych.2022.05.018_bib4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.biopsych.2021.11.024","article-title":"Negative allosteric modulation of gamma-aminobutyric acid A receptors at \u03b15 subunit\u2013containing benzodiazepine sites reverses stress-induced anhedonia and weakened synaptic function in mice","volume":"92","author":"Troppoli","year":"2022","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2022.05.018_bib5","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0285-16.2017","article-title":"A\u00a0negative allosteric modulator for alpha5 subunit-containing GABA receptors exerts a rapid and persistent antidepressant-like action without the side effects of the NMDA receptor antagonist ketamine in mice","author":"Zanos","year":"2017","journal-title":"eNeuro"},{"key":"10.1016\/j.biopsych.2022.05.018_bib6","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/ijnp\/pyx003","article-title":"Selective pharmacological augmentation of hippocampal activity produces a\u00a0sustained antidepressant-like response without abuse-related or\u00a0psychotomimetic effects","volume":"20","author":"Carreno","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2022.05.018_bib7","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/npp.2015.112","article-title":"Rapid antidepressant action and restoration of excitatory synaptic strength after chronic stress by negative modulators of alpha5-containing GABAA receptors","volume":"40","author":"Fischell","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2022.05.018_bib8","first-page":"84","article-title":"Novel benzodiazepine-like ligands with various anxiolytic, antidepressant, or pro-cognitive profiles","volume":"5","author":"Prevot","year":"2019","journal-title":"Mol Neuropsychiatry"},{"key":"10.1016\/j.biopsych.2022.05.018_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41380-020-0727-3","article-title":"Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders","volume":"26","author":"Prevot","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2022.05.018_bib10","article-title":"Quantifying the probability of pharmacological success to inform compound progression decisions","volume":"15","author":"Zhou","year":"2020","journal-title":"PLoS One"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322322012744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322322012744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:07:22Z","timestamp":1762099642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322322012744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0006322322012744"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2022.05.018","relation":{},"ISSN":["0006-3223"],"issn-type":[{"type":"print","value":"0006-3223"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From Ketamine to Drugs Targeting Subtype-Selective Benzodiazepine Site-Containing Gamma-Aminobutyric Acid A Receptors as Novel Rapid-Acting Antidepressants","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2022.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2021.11.024","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}